Epigenetic Cancer Therapy 2nd Edition

Grab your attention with the definitive resource on a fast-evolving frontier in oncology: Epigenetic Cancer Therapy, 2nd Edition by Steven Gray. This thoroughly updated volume brings clarity to the complex science of epigenetics and its growing impact on cancer treatment, making it essential for clinicians, researchers, and advanced students worldwide.

Dive into clear, engaging explanations of epigenetic mechanisms, drug classes, and translational strategies that bridge laboratory discoveries and clinical practice. The book carefully surveys current therapeutic modalities—targeting DNA methylation, histone modification, and chromatin remodeling—while examining biomarker development, resistance mechanisms, and combination regimens that enhance patient outcomes. With a focus on evidence-based applications, it highlights recent clinical trial trends and practical considerations for integrating epigenetic agents into multidisciplinary care.

For oncologists and translational scientists in North America, Europe, Asia-Pacific and beyond, this edition offers actionable insights to inform research design, therapeutic decision-making, and personalized medicine approaches. Students and pharmaceutical professionals will find concise syntheses of preclinical models, regulatory pathways, and trial design that accelerate drug development.

If you want a single, reliable reference that balances scientific rigor with clinical relevance, Epigenetic Cancer Therapy, 2nd Edition by Steven Gray delivers. Enhance your practice, research, or coursework with a resource engineered for clarity and impact. Order your copy today and stay at the forefront of epigenetic oncology.

Note: eBooks do not include supplementary materials such as CDs, access codes, etc.